Ignite Creation Date:
2025-12-26 @ 4:01 PM
Ignite Modification Date:
2026-04-15 @ 7:49 AM
Study NCT ID:
NCT06961006
Status:
RECRUITING
Last Update Posted:
2025-12-05
First Post:
2025-04-29
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Clinical Study of V940 and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)
Sponsor:
Merck Sharp & Dohme LLC
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Malignant Melanoma | View |